NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

508 hedge funds and large institutions have $10.3B invested in Neurocrine Biosciences in 2023 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 157 increasing their positions, 197 reducing their positions, and 30 closing their positions.

Holders
508
Holders Change
+54
Holders Change %
+11.89%
% of All Funds
8.1%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
89
Increased
157
Reduced
197
Closed
30
Calls
$71.2M
Puts
$54.7M
Net Calls
+$16.5M
Net Calls Change
+$2.59M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$290M
2
VRS
2
Virginia Retirement Systems
Virginia
$67.6M
3
FCM
3
Farallon Capital Management
California
$50.4M
4
Millennium Management
4
Millennium Management
New York
$143M
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$65.8M

Top Sellers

1
Amundi
1
Amundi
France
$34.5M
2
WP
2
Woodline Partners
California
$34.1M
3
Citadel Advisors
3
Citadel Advisors
Florida
$82.8M
4
Man Group
4
Man Group
United Kingdom
$37.6M
5
AC
5
Armistice Capital
New York
$137M
Name Holding Trade Value Shares
Change 		Shares
Change %
PL
526
Perpetual Ltd
Australia
– -$214K -2,268 Closed
KI
527
Kapitalo Investimentos
Brazil
– -$44.5K -472 Closed
VSQM
528
V-Square Quantitative Management
Illinois
– -$13.5K -143 Closed
TCOV
529
Trust Company of Vermont
Vermont
– -$10K -106 Closed
TAIM
530
TD Ameritrade Investment Management
Nebraska
– -$7K -74 Closed
SF
531
Safeguard Financial
Wisconsin
– -$2K -23 Closed
IPW
532
Impact Partnership Wealth
Georgia
– -$1.89K -20 Closed
CPG
533
Cornerstone Planning Group
New Jersey
– -$1.23K -13 Closed
NC
534
NewSquare Capital
Pennsylvania
– -$566 -6 Closed
2L
535
25 LLC
Missouri
– -$481 -5 Closed
AWM
536
Abound Wealth Management
Tennessee
– -$472 -5 Closed
DI
537
Disciplined Investments
Oklahoma
– -$377 -4 Closed
18 19 20 21
22